Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School. Dr. Green sees patients and conducts empirical research around the medical, behavioral and economic outcomes associated with the implementation of genomic medicine. He is Associate Director for Research of Partners HealthCare Personalized Medicine and a member of the Executive Committee for the Partners BioBank. A graduate of Amherst College and the University of Virginia School of Medicine, Dr. Green earned a Masters of Public Health in epidemiology from Emory University School of Public Health. He led the first experimental trials disclosing common complex disease risk (REVEAL Study) and one of the first prospective studies of direct-to-consumer genetic testing services (PGen Study). He currently leads and co-leads the first randomized trials to explore the implementation of medical sequencing in adults (MedSeq Project) and newborns (BabySeq Project), respectively. In 2014, he won the Coriell Prize for Scientific Achievement in Personalized Medicine.